Tennessee Oncology, PLLC/The Sarah Cannon Research Institute — Chattanooga, Tennessee

Tennessee Oncology, PLLC/The Sarah Cannon Research Institute is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Tennessee Oncology, PLLC/The Sarah Cannon Research Institute has participated in 3 clinical trials.

Therapeutic areas: UC (Urothelial Cancer), Lung Cancer.

Sponsors: Incyte Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology, PLLC/The Sarah Cannon Research Institute?

Tennessee Oncology, PLLC/The Sarah Cannon Research Institute has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology, PLLC/The Sarah Cannon Research Institute conducted?

Tennessee Oncology, PLLC/The Sarah Cannon Research Institute has 3 clinical trials on record. Their work covers UC (Urothelial Cancer), Lung Cancer.

Is Tennessee Oncology, PLLC/The Sarah Cannon Research Institute accredited by Crixeo Clinical Trials?

Tennessee Oncology, PLLC/The Sarah Cannon Research Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tennessee Oncology, PLLC/The Sarah Cannon Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.